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Tech Companies and Public Health Care in the Ruins of COVID 
 
SHINJOUNG YEO1 
Queens College, City University of New York, USA 
 
The COVID-19 pandemic has proven the cruelty of the U.S. market-driven health care 
system that disproportionately affects the poor. It illuminates how much a well-funded 
public health care system is vital for the survival of all. However, amidst the ruins of the 
pandemic and economic crisis, digital capitalism is driving a new round of capitalist 
restructuring with the health care sector at the center of capital’s new digitization push. 
Tech companies are at the forefront of this capitalist endeavor. Long before the outbreak, 
these companies and others have been cultivating the health sector into their profit-
making enterprise. The pandemic has further opened the door. This article demonstrates 
how tech companies are weaving themselves into the medical-industrial complex built 
over the last several decades. By exploiting the pandemic, they are quickly grasping an 
opportunity to occupy the public health system. 
 




At the time of this writing in 2021, the coronavirus is ravaging the planet, killing hundreds of 
thousands of people, and exposing the undeniable violence of the capitalist system that treats public health 
as a profit-making enterprise that harshly and disproportionately affects the poor who already subsist with 
few if any social protections. With the absence in the United States of publicly funded universal health care 
provision for most of its citizens, private companies are “stepping up” as they are loath to let any crisis go 
to waste. In particular, the tech giants are flexing their muscles with their industrial-scale tech infrastructure 
and deep pockets to take over the United States and world health care sectors. In response to the crisis, 
Google and Apple were even willing to collaborate to build coronavirus contact-tracing apps. Bill Gates 
announced that the Bill & Melinda Gates Foundation would invest millions of dollars to cope with the virus2; 
Mark Zuckerberg’s philanthropy group—the Chan Zuckerberg Initiative—pushed large amounts of private 
funding toward increasing coronavirus testing in the Bay Area; Amazon shifted its shipping priority toward 
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1 Thanks to Dan Schiller, Richard Maxwell, and James Jacobs for feedback on various drafts of this article. 
2 Bill & Melinda Gates Foundation has been a major player in the global health arena. Through philanthropic 
work, the foundation has long promoted market solutions and opening markets for the pharmaceutical 
industry. For further discussion, see Loffredo and Greenstein (2020) and McGoey (2015). 
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high-demand medical supplies. Eric Schmidt, Google’s former CEO, publicly hoped that people would be 
more grateful for big tech once and for all (Schleifer, 2020). 
 
Is this unprecedented crisis finally reorienting the profit-motivated nature of these tech companies 
toward treating health care as a public good? Or, given the recent backlash against these Silicon Valley tech 
giants, are their COVID-19-related initiatives merely part of their more cynical, merely clever public relations 
strategies? The answer is neither. Long before the coronavirus outbreak, the health care sector had been a 
target for tech companies. Because the tech giants have drawn much media attention for their monopolistic 
behavior in various tech sectors—search, e-commerce, and social media—their long-term business 
ambitions in the health sector are less known to the public. As the coronavirus crisis deepens and accelerates 
around the world and another capitalist crisis reminiscent of the 1930s looms, the tech industry is seizing a 
new business opportunity in the health care sector and exploiting the pandemic for its own profit. 
 
Deploying critical political economy, which looks at the process of commodification of information 
and communication, the relationship between information and communication technologies and evolving 
capitalism, concentration of corporate power, and policies shaping the Internet industry (McChesney, 2013; 
Mosco, 2009; Wasko, 2014), this article shows how Google, Amazon, Apple, and Microsoft are augmenting 
the already heavily privatized health sector as a new field of profit-making during the pandemic. The purpose 
of this article is to call attention to the continuing process of commodification and commercialization of the 
public health and health care services sectors, which is now being accelerated by tech companies with the 
support of the state during the pandemic. 
 
Before explicating how the Internet giants have interwoven themselves into the health care sector 
and capitalized during a crisis of capitalism triggered by the pandemic, this article begins with the concept 
of digital capitalism, which is instructive as it situates today’s dynamics of capitalism within the crisis-ridden 
evolution of capitalism. The article concludes with a call for a long-overdue public ownership of the health 
care network infrastructure. 
 
Crisis of Capitalism 
 
Historian Ellen Wood (2016) succinctly recounts that capitalism brings “the compulsions of 
competition, profit-maximization, capital accumulation, and a relentless imperative to improve the 
productivity of labor so as to reduce costs in order to reduce prices” (para. 13). Capitalism is prone to crisis 
with what some analysts call “overaccumulation”: a condition that occurs when surplus capital reaches 
market absorption capacity resulting in declining rates of profit. To overcome the crises that result, Harvey 
(2003) argues that capital attempts to develop new markets, what he calls a “spatio-temporal fix” (p. 109). 
Drawing from Harvey, D. Schiller (1999, 2011) posits that in response to the economic downturn of the 
1970s, the U.S. political economy further pivoted to information and communication technologies as a 
spatio-temporal fix to restructure the economy by creating networked information systems to expand 
business processes as well as to renew profitable growth. In 2020 alone, investment in information and 
communication technologies amounted to $4.3 trillion spread across economic sectors and providing an 
essential foundation for digital capitalism. 
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D. Schiller (2014) theorizes that digital capitalism is similar to “industrial capitalism”: “the far-
reaching political economic mutations in the 19th century that were being introduced around new forms of 
machinery in England and increasingly elsewhere” (p. 8). As industrial capitalism absorbed machinery into 
production processes, digital capitalism has been incorporating digital machineries. The process has 
accelerated as a result of the contemporary crisis of capitalism and the intensification of pressure to increase 
productivity and control labor processes while maintaining the existing modes of production and the 
dominant social order. The political economy’s voracious embrace of digital technology is described by many 
scholars as a new form of capitalism; they use various terms such as surveillance capitalism (Zuboff, 2019), 
cognitive capitalism (Moulier-Boutang, 2011), and informational capitalism (Castells, 2010). However, 
digital capitalism is not a new order that breaks fundamentally with the earlier history of agricultural and 
industrial capitalism; rather, it is firmly situated within the compulsions and imperatives and crisis 
tendencies of this type of political economy (D. Schiller, 2014). 
 
Today, digital capitalism grips every sector, as it has expanded and extended beyond information 
industries and reorganized the entire economy from manufacturing production to finance, science, education, 
and the arts, and impacts every iota of people’s social lives. The current growth of the health sector driven by 
tech companies needs to be situated within the context of the development of digital capitalism. 
 
The crisis of 2007–2009 was never fully resolved; instead, it has reappeared and been greatly 
aggravated by COVID-19. In January 2020, the World Bank warned of a fresh new wave of global debt 
crisis, describing “the largest, fastest and most broad-based” increase since the 1970s (Elliot, 2020, para. 
2). The International Monetary Fund (IMF) projected that the global economy would contract by 4.9% in 
2020 (World Economic Outlook, 2020). In the midst of this maelstrom, digital capitalism is driving a new 
round of capitalist restructuring with the health care sector at the center of capital’s new digitization push. 
In the era of COVID with the compounded economic crisis, the long-existing medical-industrial complex has 
been enabled as a key part of the spatial-temporal fix required by capital. Tech companies are at the 
forefront of this capitalist endeavor as they are asserting their power into the complex where access to 




The commodification of medicine in the United States goes back to the 19th century, as capital 
brought science under its sway as a means of production and gave rise to the modern science-based industry 
(Noble, 1979). During industrial expansion, the pharmaceutical industry arose with systemic and systematic 
applications of science and research that rationalized and transformed medicine into a capital-intensive large-
scale industry (Brunton, 2013). Early science-based industry—in particular the electrical and chemical sectors—
established corporate research arms and drew in universities to serve corporate interests. By 1931, more than 
16,000 companies including pharmaceutical firms supported in-house industrial research labs (Reich, 2002). 
 
In the post-World War II era of Big Science, the federal government heavily funded medical 
research, development of medical technologies, and hospital construction, as medicine was increasingly 
specialized and focused on advanced technologies that drove the expansion of the private health industry 
(Tomes, 2006). This brought a closer link among government, medical research, drug companies, and health 
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care networks became increasingly intertwined, thus beginning the rise of the “medical-industrial complex” 
(Ehrenreich, 2016, p. 57). 
 
By the 1970s, medicine had clearly become a profit-making site for Wall Street financiers and 
industrial capitalists, backed by the capitalist state in the throes of the oil crisis, which forced the U.S. economy 
into economic stagnation and a search for new growth sectors. Barbara and John Ehrenreich, in the Health/PAC 
Bulletin published by the Health Policy Advisory Center—a hub of health care activism in the late 1960s—
described the U.S. for-profit health care system as a medical-industrial complex consisting of a network of 
health care corporations, with academic enterprises and government closely tied to and serving corporate 
interests. The complex grew during the 1980s with a new wave of privatization and deregulation in response 
to the worldwide economic downturn, an era of neoliberalism. Driven by the slogan “Don’t just stand there, 
undo something,” the Reagan administration actively injected market principles into the expanding health care 
industry, alarming even medical professionals (Goodman & Loveman, 1991, para. 2). 
 
In the 1980s, Arnold Relman, editor of The New England Journal of Medicine, observed the 
emergence of profit-driven health services in hospitals, nursing homes, homecare services, and diagnostic 
services. To describe the ascendance of this new industry around health care, he deployed the concept of 
the “new medical-industrial complex” (Relman, 1980, p. 963). He described every segment of the field as a 
new medical-industrial complex, excluding the pharmaceutical industry that had emerged in the 19th 
century. With the zeal of probusiness policy, Marcia Angell (2005), another former New England Journal of 
Medicine editor, also pointed out that the 1980s was “the fundamental element in the rapid rise of big 
pharma” (p. 6). And beyond the prevalent private firms in medical services and the power of big pharma, 
Starr (1982) noted that there was not only privatization and corporatization, but also concentration and 
consolidation in the health industry throughout the 1980s and 1990s. Furthermore, corporate power over 
health care systems was further strengthened by a series of U.S. government science and technology 
policies between 1977 and 2001 that brought the medical scientific communities closer to venture capital 
and moved further away from building health care for people. 
 
The Bayh–Dole Act of 1980, signed into law by President Jimmy Carter—drawn from the 1980 
Stevenson–Wydler Technology Innovation Act—followed by the Federal Technology Transfer Act of 1986 
spurred universities to commercialize patents resulting from their faculties’ federally funded research. Under 
these policies, research institutions were given intellectual property (IP) rights so that they could license 
patents to the private sector. Pre-Bayh–Dole, there were fewer than 250 patents per year issued to 
universities. By 2005, several thousand patents were being issued to universities every year (Furcht & 
Hoffman, 2014). In particular, during the first 25 years under Bayh–Dole, almost 70% of universities’ 
patents were in the fields of biotechnology and the life sciences (Furcht & Hoffman, 2014). One of the major 
results of this market-driven science policy was the acceleration of the commercialization of life sciences 
research given that the fruits of publicly funded research on which big pharma relied were transferred to 
the pharmaceutical industry (Angell, 2005). This meant an increase in the enclosure of access to life-saving 
medicines by locking up IP and patents for longer periods of time rather than producing affordable medicines 
for people. This process—accumulation by dispossession—is based on taking away from people with little to 
generate more wealth for the rich (Harvey, 2003). 
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Recently, the Bayh–Dole Act has drawn fresh attention from the pharmaceutical industry as the 
U.S. government has committed to spending almost $10 billion through “Operation Warp Speed” to develop 
a new coronavirus vaccine, including $3 billion for coronavirus research through the National Institutes of 
Health (NIH) working with drug companies (U.S. Department of Health and Human Services, 2020a). In 
fact, the pharmaceutical company Moderna received $483 million from the U.S. government (Langreth, 
2020). To ensure their exclusive licenses, the pharmaceutical industry quickly responded by launching a 
new coalition called Bayh–Dole 40 to prevent the government from using its “march-in right,” a provision 
included in the legislation whereby the federal government could “march in” in certain circumstances and 
issue compulsory licenses. So far, the U.S. government has never exercised the provision, but the industry 
wanted to make sure that the pandemic would not be the first time when so much money stood to be 
gained. 
 
Corporate control over vital medical knowledge and research has been replicated across the globe 
for decades. Wealthy countries, led by the United States, have shaped the global IP regime through the 
rules-making process within the Trade-Related Aspects of Intellectual Property Rights agreement under the 
auspices of the World Trade Organization. The agreement was adopted in 1994, and has imposed an IP 
regime that facilitates corporate monopolies in all fields of knowledge production on which people’s lives 
hinge, including medicine, plants, and seeds. IP has long been used by the Global North as an instrument 
for looting the Global South, transforming basic human knowledge into commodities and exercising 
monopoly power over them (Mgbeoji, 2014). The agreement deprives many countries in the Global South 
of the ability to develop and access cheap and affordable generic drugs by imposing an IP dominated by 
corporate interests and denying millions of people access to essential medicines (Greene, 2014). Thus, it is 
no surprise that the development of coronavirus vaccines to save people’s lives now depends on the mercy 
of corporations. 
 
In developing COVID-19 vaccines, diagnostics, and drugs, the majority of patents that are needed 
are in the hands of big pharma. Facing this global public health crisis, the World Health Organization (WHO) 
passed a resolution calling for a voluntary patent pool of rights related to patented COVID-19 technologies. 
UN Secretary General Antonio Guterres (2020) implored, 
 
A world free of COVID-19 requires the most massive public health effort in global history. 
. . . Data must be shared, production capacity prepared, resources mobilized, communities 
engaged and politics set aside. . . . COVID-19 anywhere is a threat to people everywhere. 
 
It is necessary to create a common pool to collect patent rights, test data, and other information 
in order to develop drugs, vaccines, and diagnostics for the global population. However, the question 
remains whether pharmaceutical companies will cave to global pressure to join the patent pools. The United 
States, along with the UK, Switzerland, and Japan, has had the strong pharmaceutical industry push back 
against the WHO’s call for a global IP pool to secure COVID-19 drugs for everyone. The Unites States under 
the Trump administration even officially withdrew from the WHO, although the new Biden administration 
has rejoined the organization. 
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Within this context of the U.S.’s institutional arrangement of the medical-industrial complex, which is 
constituted by the State and a neoliberal health care policy framework, for-profit and privately owned health 
care corporations, and university and college research that largely serves this political economy at the expense 
of people’s need for accessible and equitable health care, Big Tech companies are now positioning themselves 
to capitalize on the digitization of health care and gaining access to people’s health data. 
 
Digitization of Health Care 
 
The tech giants are particularly eager to get their hands on health data and promote their own 
access to the data during the pandemic; as well, there has long been support by the federal government to 
digitize health records as part of the promotion of the “new” economy. In the 1990s, the Clinton 
administration, which privatized the publicly funded Internet, began the push for electronic health records 
(EHRs) by enacting the Health Information Portability and Accountability Act (Carter, 2008, p. 307). The act 
incentivized health care providers to accelerate the deployment of EHRs; however, major adoption of EHRs 
did not occur until the Obama administration, which accelerated President George W. Bush’s policy on the 
computerization of health records (White House, 2004). 
 
In response to the Great Recession of 2008, the Obama administration, as part of the economic 
stimulus put forth by the American Recovery and Reinvestment Act of 2009, allocated $27 billion for EHRs 
through the Health Information Technology for Economic and Clinical Health (HITECH) Act. The HITECH Act 
was created to promote the use of EHRs by health care providers. In fact, the digitization of health records 
was one of the Obama administration’s priorities, attained with the passage of the HITECH Act. The law 
creating the EHR program promoted meaningful use to incentivize hospitals and health care providers to 
digitize health records and adopt EHR systems. The logic behind “meaningful use” as part of the national 
recovery act was to spur the growth of the health care tech industry. 
 
Soon after the passage of the HITECH Act, President Obama signed Executive Order 13642, “Making 
Open and Machine Readable the New Default for Government Information” (2013). Following that order, 
the Food and Drug Administration (FDA) launched a project called OpenFDA, opening up machine-accessible 
health data sets such as genomic data, active and inactive ingredients, regulatory and clinical research, and 
patents. OpenFDA allows people to quickly find and access millions of redacted patient records as well as 
providing an application programming interface (API) to major structured data sets for developers and 
researchers. There is little question that the use of these health data should be treated as a social good in 
support of the public interest. The initiative was presented as public access to medical information; however, 
it was more about releasing valuable data collected at taxpayer expense to the tech sector so that tech 
companies could recompute and repackage them into a new commodity. In fact, these big data sets are not 
useful for everyday citizens because they require a value-added interface, computational power, and 
technical skills. This is not unprecedented. In the 1980s, Herbert Schiller (1981) showed how remote sensing 
data including soil, weather, and other planetary information should be treated as a global social utility, but 
was instead turned over to private companies that had technical capability and processed the data for purely 
corporate interests. 
 
President Obama did not hide his intentions, stating, 
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One of the things we’re doing to fuel more private sector innovation and discovery is to 
make vast amounts of America’s data open and easy to access for the first time in history. 
And talented entrepreneurs are doing some pretty amazing things with it. (White House, 
2013, para. 4) 
 
In fact, part of the Obama health care reform enriched Silicon Valley by incentivizing the 
development of health care technologies and health care infrastructure designed to accelerate the adoption 
of digital technologies. 
 
Under the Trump administration, the policy on health data was changed from meaningful use to 
interoperability, because without interoperability, the data have limited use. On March 9, 2020, the 
administration issued two policies by the Health and Human Services Office of the National Coordinator for 
Health Information Technology and Centers for Medicare & Medicaid Services—the 21st Century Cures Act 
as an amendment to the HITECH Act and the MyHealthEData initiative (U.S. Department of Health and 
Human Services, 2020b). 
 
These data-sharing policies require health care providers to offer patients access to their own 
records and the interoperability of these data among providers, patients, and third-party apps. The 
administration touted this as “data at the point of care,” which would empower patients and give them the 
freedom to control their own records (Centers for Medicare & Medicaid Services, 2020, para. 2). 
 
However, this illusion of freedom, which shifts data control from health care providers to individual 
patients, carries significant implications not only for privacy, but also for control over data. First, when the 
data leave hospital systems, they are no longer protected by the medical privacy provisions within HIPAA. 
Second, the individually owned health data can be easily transferred to third parties and mined by tech 
companies. It is also important to note that the digitization of the health sector and promotion of access to 
health data were done in conjunction with the defunding of public health care and exploitation of underpaid 
health care workers. Besides privatized employer-sponsored health care, which has left 15% of Americans 
without health care during the pandemic, between 2005 and 2020, public health funding in the United 
States, including staff, training, equipment, and supplies, decreased 45% adjusted for inflation (O’Donnell, 
2020). Since the 2008 Great Recession, local and state health departments have lost more than 51,000 
jobs, or almost 19% of the workforce (Wilson, 2020). Worse yet, amid the pandemic, the defunding of 
health care has continued as President Trump’s 2021 budget has proposed a cut for the Department of 
Health and Human Services, including a 15% cut in Centers for Disease Control and Prevention funding and 
a $900 billion cut to Medicaid over 10 years (Berg, 2020). 
 
An anemic public sector and a political economy that has long permitted exploitative corporate data 
practices in and around medicine and health have created conditions allowing tech companies to swiftly exploit 
the present moment of data-intensive and surveillance business across the entire medicine and health sector 
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Here Come the Tech Giants 
 
The global digital health market is expected to reach $639 billion by 2026 (Global Market Insights, 
2020) and is undergoing a rapid digitization process, accelerating “datafication”: the conversion of our social 
activities into quantified data that enables the use of information in new ways (Mayer-Schönberger & Cukier, 
2013, p. 36). The tech giants are intensifying datafication as a profit-making business model by deploying 
their industrial-sized Internet infrastructure and transforming themselves into what Srnicek (2017) calls 
“platform firms,” which work as intermediaries connecting and interacting with various users and also 
enabling the building of third-party marketplaces. Google, Amazon, Apple, and Microsoft are developing 
potentially lucrative sectoral health platforms to commodify the public value of health data (van Dijck, Poell, 
& de Waal, 2018, p. 98) as they are moving into what Fields (2004) calls “new territories of profit making” 
(p. 230). Google is leading the pack. 
 
More than a decade ago, Google began to dabble in health care under the radar. The company 
launched a personal health record service called Google Health in 2006, which allowed users to store and 
manage their health care information. After five years without success, Google shut down Google Health. 
But the company soon reorganized its efforts, boosting health-focused Google search G Suite for health care 
businesses, and creating subsidiaries devoted to various health sectors. In 2015, Google established its 
health care division Verily Life Science, previously known as Google Life Sciences. Google scooped up a 
couple of former Obama staffers, hiring former FDA commissioner and cardiologist Robert Califf as its head 
of strategy and policy and former Obama health official Karen DeSalvo as its first chief health officer. They 
play interlocutors among Verily and the health care industry, research institutions, and the government. 
However, Google’s Verily did not just come out of thin air; rather, it coincided with President Obama’s 1-
million-volunteer health study as part of his Precision Medicine Initiative, funded by NIH and the National 
Cancer Institute to collect patient data through the institutes’ funded long-term research (Sankar & Parker, 
2017). Verily was deeply involved in the initiative, as NIH selected Verily and Vanderbilt University to work 
on the first stage of the Precision Medicine Initiative, cannibalizing existing public health institutions as they 
were being weakened by the withdrawal of funding. 
 
For years, Google has been actively laying the groundwork to cultivate its health care business, 
embarking on a series of projects to build its health care information technology infrastructure to collect, 
store, and analyze patient data (van Dijck et al., 2018). The company has been extending partnerships with 
major hospital systems and health care providers to access tens of millions of patient records including 
medication needs, allergies, vaccinations, existing and previous illnesses, and test results (Copeland, 2019). 
Google has hoovered up medical records from more than 2,600 U.S. hospitals without informing patients or 
doctors as part of a machine-learning project named Nightingale. Since 2018, Google has been working with 
Ascension Hospitals, one of the nation’s largest health systems, which shared the data of millions of patients 
with Google to develop a health-related search tool and AI tools for diagnostics and medications. This had 
alerted Health and Human Services’ Office for Civil Rights, and Google is currently under investigation by 
the agency over its data use. 
 
And given that Google operates globally, Google’s ambition to collect health data is not limited to the 
United States. In 2019, to get access to bulk health data in the UK, Google acquired and incorporated into 
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Google’s health division the London-based AI company DeepMind Health. DeepMind Health signed an 
agreement with five hospitals in the National Health Service to share health data including treatment dates, 
medical history, diagnoses, ethnic origin, and religion (Vaughan, 2019). The company has free access to the 
data while it is building propriety products to monopolize market power (van Dijck et al., 2018). Google had 
already applied for a patent on a method for aggregating EHR patient records to predict medical outcomes. 
 
With its focused amassing of health data and entrance into the health care industry, Google is 
also deeply integrating itself into the medical-industrial complex. The company has its sights set on the 
clinical trial space, which is projected to be a $69 billion market by 2026. Google’s Verily has built a 
strategic alliance with major pharmaceutical companies like Pfizer Novartis, Sanofi, and Otsuka, targeting 
the clinical trial market with its technologies and infrastructure, promising to speed up clinical trial 
recruitment, collecting data, and managing the workflows of clinical trials. The company describes its new 
venture as democratizing clinical trials and a patient-centered approach to research (Lee, 2020). To 
“modernize” the clinical trial process, Google sells its services drawn from facilitating patient enrollment 
in trials to aggregate data from various sources including health-tracking wearable devices and 
pharmaceutical companies. Moreover, Google is no longer just a purveyor of technologies, but rather has 
turned into a pharmaceutical company in its own right. Verily has partnered with the European 
pharmaceutical giant GlaxoSmithKline and formed a new drug company called Galvani Bioelectronics for 
the development of bioelectronic medicine, which is a branch of medicine that uses electronic signals for 
treatment (Vincent, 2016). 
 
Verily has also been working on a large-scale five-year research project called Project Baseline to 
design health care tools and services with Duke and Stanford’s schools of medicine. The project has recruited 
10,000 volunteers for their research, following their subjects for four years and collecting data on their 
lifestyles, activity levels, sleep habits, and diet deploying machine learning, fitness trackers, physical check-
ups, and genetic testing (Rosenberg, 2018). 
 
Accumulated EHR data will be stored in Google Cloud, computed and fed into Google’s “personalized 
data-driven” health care service business. As Google turned its search technology into a point of control 
between users and content owners, Google is now inserting its “big data” power and digital technologies—
search, cloud infrastructure, data mining, and AI—among doctors, medical institutions, the health industry, 
and patients. 
 
To fully integrate these digital technologies at the core of human health, Google is even betting on 
genome data from around the world, and has launched its Cloud Life Science (formerly Google Genomics). 
Cloud Life Science sells an API to store, process, and analyze DNA sequences on the Google Cloud platform. 
Google is not alone in the game. Amazon, Microsoft, and IBM are all in the race for genome data as well, 
with the global genomics market expected to reach $35.7 billion by 2024 (Market Watch, 2021). 
 
Leveraging its massive computing power with the field of genomics, Google formed a secretive 
biotech company called Calico Labs in 2013 with a mission “to build a Bell Labs of aging research” (Regalado, 
2016, para. 2). Calico has partnered with Chicago-based pharmaceutical giant AbbVie to work on anti-aging 
drugs. The company is paving the way for its pharmaceutical business portfolio as Google’s GoogleVenture 
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arm has backed several biotech companies centered around antiaging, flu vaccines, and gene therapies. 
Besides forging relationships with pharmaceutical companies, Calico is working with MIT and Harvard’s 
Broad Institute, a biomedical and genomic research center looking to develop new drugs on anti-aging, a 
$56+ billion market as of 2020 (Shahbandeh, 2020). 
 
Google’s competitor Microsoft has long been present in the health care sector. But in 2017, the 
company officially established a health department in its Cambridge research lab to vie for business 
opportunities in several health fields that intersect with Google, specifically cloud, AI, machine learning, 
genomics, precision medicine, telemedicine, and health data cybersecurity. In 2018, Microsoft had 1,100 
people working in its health unit and 14,000 partners with health care providers (Kharpal, 2018). The 
company kicked off its Healthcare NExT initiative to push its AI and cloud products, selling health care 
data storage and sharing platforms as well as AI-powered virtual heath “assistants.” In January 2020, 
Microsoft officially launched the $40 million five-year project AI for Health to burrow into the health care 
sector by recruiting a mix of nonprofits, academics, industry, and governments to experiment with AI and 
cloud tools for studies on everything from diabetic retinopathy, tuberculosis, maternal mortality, to cancer 
(Coldewey, 2020). 
 
Meanwhile, Apple CEO Tim Cook said, “The healthcare market makes the smartphone market look 
small” (CB Insights, 2019, para. 2), recognizing the trillions of dollars in health care spending annually or 
about 10% of global GDP. Apple considers health and wellness at the center of its app, services, and 
wearables strategy. The company has several health-related services such as HealthKit, CareKit, and 
ResearchKit giving access to health data to patients, researchers, and developers through various mobile 
devices (Farr & Sullivan, 2016). In 2018, Apple released its personal health record feature called Health 
Records, which aggregates patient-generated data in the health app combined with patients’ electronic 
medical records from their health care providers. Apple is working with a growing list of major hospitals in 
the United States including Stanford Medicine, Scripps, New York University Langone Medical Center, and 
the U.S. Department of Veterans Affairs (Comstock, 2018). 
 
Amazon, which has mastered the supply chain for its e-commerce business and has built a massive 
cloud infrastructure, has made inroads into the health care supply chain. The company has moved into the 
area of consumer medical devices, pharmacy services, and medical care services. It acquired online 
prescription service PillPack and has already filed for a trademark for the name Amazon Pharmacy. Amazon 
created a “Health & Wellness” team within their Alexa voice assistant division to use Alexa in health care. 
Alexa has been deployed in hospitals and, by attaining HIPAA compliance, allowed Alexa to access 
consumers’ prescription medications, personal health information, medical appointments, and insurance 
(Perez, 2019). Amazon also introduced Amazon Comprehend Medical, which uses text analysis and machine 
learning to read patient records—prescriptions and test reports—uploading the data to its cloud platform to 
organize data about diagnoses, treatments, and symptoms (Shu, 2018). By exerting its various health care 
technologies and vast technical infrastructure, Amazon has been able to embed itself more deeply into the 
health market. It has rolled out its health care service Amazon Care to its employees and other companies, 
which encompasses the entire medical encounter including telemedicine along with in-person service, online 
chat with nurses, and medication delivery. 
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Not to be left out, Facebook requested that major U.S. hospitals share anonymized data about their 
patients for their research project (Farr, 2018). Although Facebook’s demands fell through, this did not 
stymie the company from launching its Preventive Health tool, which offers check-up reminders, scheduling, 
and health resources. It shows that the company is eager to exploit the health care market along with its 
major competitors that are already increasingly investing resources and occupying the sector. Besides these 
leading tech companies, IBM, Oracle, Intel, CIA-funded Palantir, Uber, Samsung, and Tencent are all betting 
on health care as their next “big thing.” 
 
Exploiting the Pandemic 
 
A crisis is an opportunity for corporate capital to find new markets for continued growth and profit 
(Huws, 2011). Indeed, the tech giants are profiting from the pandemic while the Trump administration 
neglected its responsibilities in directing an ill-equipped health care system and hollowed-out federal 
pandemic response team. Without mentioning the failure of the market-driven health system, tech 
companies purport that the lack of proper health care for everyday people is due to insufficient and inefficient 
technologies rather than the record of political choices. They have positioned themselves as the solution for 
this current plight, exercising their industrial strength technologies and political and economic power. New 
York Governor Andrew Cuomo recruited tech billionaires Bill Gates, Eric Schmidt, and others to “reimagine 
New York” from the ruins of the pandemic that has laid bare New York’s crumbling social infrastructure after 
40 years of neoliberal policies designed to shrink the social safety net and punish the poor. Eric Schmidt will 
lead a 15-member commission to improve telehealth and broadband systems across New York State. 
Schmidt said, “The first priorities of what we’re trying to do are focused on telehealth, remote learning and 
broadband. . . . We can take this terrible disaster and accelerate all of those in ways that will make things 
much, much better” (Klein, 2020, para. 4). It is clear that the priorities are not about providing basic human 
needs—food, health care, shelter, and education—rather they are again prioritizing the needs of corporate 
capital by further opening up critical public services for corporate interests. 
 
Not coincidentally, the Trump administration deregulated telehealth policy including HIPAA rules, 
further incentivizing the adoption of telehealth (Boyd, 2020). Although telehealth is valuable for the public, 
just deploying more digital technologies will not challenge the disparities inherent in the capitalist health 
care system; rather, it feeds and exacerbates the inequities of the market economy. Google has already 
rolled out several coronavirus-related projects: telehealth, online self-screening surveys, the virus screening 
platform, and antibody research study for COVID-19. Google’s Verily is working on antibody research with 
scientists at Duke University as part of the Healthcare Worker Exposure Response and Outcomes research 
program. Google, with Palantir, Microsoft, and Amazon are involved in the UK’s National Healthcare Service, 
supporting software, data collection, and cloud platform (Sonnemaker, 2020). 
 
Microsoft, which has enjoyed a stock surge with strong growth in its cloud service, launched its 
health industry-specific cloud offerings incorporating its existing products like chatbots, teams, and Azure 
IoT. Microsoft’s Healthcare Bot Service has gone live and been deployed in medical facilities in 23 countries. 
The Microsoft Azure-based virtual service uses AI to answer people’s questions, purporting to alleviate 
workload for medical staff and better care for patients. In particular, global health care cloud computing is 
one of the most lucrative markets, set to hit over $51 billion by 2024 (McGrail, 2020). For Apple, with its 
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iPhone sales falling because of the coronavirus, economic slowdown, mobile market saturation, and 
contention between the United States and China, the expansion into the health care sector has become even 
more important. Apple subsidiary Claris, which sells the low-code application development software 
FileMaker, has pushed its service to health care providers by quickly developing apps in a day or two used 
for making real-time medical decisions (Rosenbaum, 2020). 
 
Tech companies are hailing the cloud, AI, voice search, chatbots, and virtual reality as the answers 
to the most intractable problems in health care in the United States, long waiting times to see doctors, and 
unaffordable prescription drugs. The tech giants are working toward occupying the medical and health care 
fields, but at the same time, they are also pouring in massive amounts of corporate philanthropy meant to 
draw positive mainstream media attention to show that capitalism is not just operating through brute force; 
rather, it is “compassionate,” diverting the focus away from their true base corporate interest. 
 
Rivals Apple and Google have shown their “compassion” by teaming up to launch the decentralized 
exposure notification API (Gapple API), allowing governments, public authorities, and other third parties to 
create apps on top of the API. Apple and Google boasted that to protect users’ privacy, their contact-tracing 
system would be designed to use Bluetooth, which stores data on people’s phones rather than in a central 
database. Unlike GPS-based contact-tracing systems, the Gapple Bluetooth system does not track people’s 
physical location, but rather picks up nearby cellphone signals as a substitute for GPS location data. 
 
The companies have stated that they would not share data or technical specifications with third 
parties, including governments. This project was originally called the Privacy-Preserving Contact Tracing 
Project, as Apple and Google preemptively inscribed the project with stringent privacy measures to deflect 
any criticism; both companies have faced backlashes from domestic and European regulators concerned 
about their exploitative surveillance business model. The technical design indeed solves the privacy problem, 
but it also shows the power of the two tech giants and how they control the digital technology terrain. 
 
Although this decentralized approach was initially praised by European regulators who have long tried 
to rein in the U.S. tech giants on multiple fronts including on privacy issues, they soon realized that Apple and 
Google control all hardware, software, and all technical specifications and standards, so it is difficult if not 
impossible for countries to create their own contact-tracing applications (Newton, 2020). As The Guardian 
reported, Google and Apple permit only one app per country with approval by its government. The two 
companies set the conditions, so each country’s disease-control authority cannot access data generated by the 
app to analyze and learn more about how the pandemic is progressing in their own country (Ilves, 2020). 
 
France, Germany, Italy, Spain, and Portugal, as well as many doctors and researchers, are 
demanding that these tech companies should not “control the terms, conditions or capabilities” (Albergotti, 
2020, para. 6) of digital contact tracing, and are demanding access to their operating systems. Initially, 
European countries resisted the Gapple API, as they sought a European-designed and controlled contact-
tracing app; however, every European country except France has shifted to the Gapple API because of 
technical complications as well as lack of technical capability. Recalling comparable skirmishes during the 
debates over the new international information order, France rejected the Gapple API, stating that this is a 
matter of “technological sovereignty.” 
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Tech companies are all rolling up their sleeves and calling for “private–public” partnerships as they 
try to show the world that they are all contributing toward the fight against COVID-19. However, corporate 
philanthropic heroism inscribed with digital gospel is intended to spread their technologies as wide as 
possible from hospitals to schools to transportation as a solution to failed government policies. It also 
conceals the extent of corporate welfare that is extracted from public taxpayers while long-standing anemic 




The crisis triggered by the COVID-19 pandemic is deepening digital capitalism as tech sectors are 
raking in billions of dollars in profit. The global tech companies purport that they are offering their 
technologies for free to alleviate the current public health crisis; however, in reality, they are tightening 
their grip over this new market by precipitously building private networked health care technical 
infrastructures, further marketizing public health, and undercutting any small grassroots momentum toward 
universal health care. 
 
The strategy for tech companies is to use the crisis to make their technologies indispensable so 
that people will have to rely on proprietary technologies to access, build, and maintain each country’s health 
care system, everything from finding doctors to clinical trials. Under the guise of “improving” people’s lives 
and reducing costs, tech companies are tightly weaving themselves into the existing medical-academic-
industrial complex, restructuring insurance companies, hospitals, drug companies, and universities, and 
further commodifying basic health care. This falls into what Wood (1998) describes as the universalizing 
logic of capitalism, which imposes a market logic on all aspects of our lives. This move has to be stopped 
by claiming, broadening, and funding a public universal health care agenda. 
 
The Tricontinental Institute for Social Research, an international research institution aimed at social 
and political movements, has proposed a 10-point agenda for the Global South after COVID-19 (Prashad, 
2020). Among the 10 points, medical solidarity, creation of an intellectual commons, and investment in the 
public sector are especially pertinent to a universal health care system.3 Although the Tricontinental 
Institute’s agenda is focused on the Global South, the agenda offers an entry point to think about a 
meaningful universal health care system in the United States and other parts of the world. Building on the 
principles of solidarity, commons, and public service, the provision of universal health care should 
encompass access to free medical services for all and decommodification of medical knowledge by 
dismantling the current IP regime. Moreover, it also needs to be expanded to include public ownership of 
the technical infrastructure undergirding public health care systems. 
 
The pandemic has demonstrated that corporate-owned Internet infrastructures and services, which 
are often invisible, have become essential for our survival just like water, air, and electricity. In the midst 
 
3 Tricontinental Institute for Social Research’s 10 points: tackle the global pandemic, broaden medical 
solidarity, create an intellectual commons, cancel debt, expand food solidarity, enhance and invest in the 
public sector, implement wealth taxes, enact capital controls, shift to non–dollar-based regional trade and 
centralized planning, and decentralize public action. 
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of the pandemic, millions of people still cannot access or afford proper health care and continue to lose their 
employer-based health insurance. Our public health and survival should not be subordinated to corporate-
driven technologies, interests, and philanthropy. The crisis calls for social solidarity and putting an end to 
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